INTRODUCTION
Glial cell line-derived neurotrophic factor (GDNF) has been puri®ed from glial cell line conditioned medium on the basis of its ability to promote dopamine uptake in embryonic mesencephalic cultures [1] . In animal models of Parkinson's disease, GDNF injected into the substantia nigra (SN) or the striatum has been shown to protect lesioned dopaminergic (DA) neurons from the degenerative process induced either by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or by transection of the medial forebrain bundle [2] . Recently, the other members of the GDNF family, including neurturin (NTN), persephin (PSP) and artemin (ART), have been identi®ed [3±5] . These have been shown to exert effects on developing and lesioned central and peripheral neurons [6] . In particular, NTN, as well as PSP and ART, exert potent actions on survival and function of midbrain DA neurons. In vitro, they support survival of embryonic DA neurons. Further experiments have also demonstrated that NTN and PSP protect in vivo adult rat nigral DA neurons from 6-hydroxydopamine (6-OHDA)-induced cell death [3, 7] . These neurotrophic and neuroprotective actions of GDNF family members suggest their potential application in treatment of the neurodegenerative diseases.
During neurodegenerative process, cascades of degeneration and the subsequent regeneration are triggered. Part of mechanisms of neuroprotection in brain is to produce and release trophic factors or growth factors by local neural cells and/or target tissue in an attempt to reduce further damage. Published studies have reported that expressions of neurotrophins, ®broblast growth factors (FGF), ciliary neurotrophic factor (CNTF), transforming growth factors (TGFs) and insulin-like growth factor (IGF) are increased in the CNS against various insults. We have previously shown that the level of BDNF protein was elevated in the striatum of 6-OHDA-lesioned rats as a target-derived neurotrophic factor and this elevation appeared 2 weeks post-lesion, reaching even higher levels 4 weeks post-injury [8] . These ®ndings indicate that there is an evident delayed response of a rodent brain to insults. The possible roles of these endogenous neurotrophic factors in the brain following injury have started to be understood. In the case of NGF notably, it was shown that production of NGF by local astrocytes was increased after mechanical injury to the neostriatum. The lesion-induced increases in NGF levels was apparently associated with maintenance of striatal ChAT activity at normal levels following cholinergic injury, even with decreases in highaf®nity choline uptake [9] . However, the molecular nature of neuroprotection factors involved in the neurodegeneration of the CNS remains largely unknown and is the object of considerable interest, particularly in relation to the known growth factors. For example, it is presently unclear whether destruction of the dopaminergic nigrostriatal pathway in rat model of Parkinson's disease leads to alterations in the expression of striatal mRNAs of GDNF family. Here the possible roles of GDNF family members following destruction of the nigrostriatal pathway was examined using reverse transcriptase-polymerase chain reaction (RT-PCR).
MATERIALS AND METHODS
Animals: Female Sprague±Dawley rats (weighing 200± 220 g) and C3H/He mice (weighing 25±30 g) were provided by the Animal House, Institute of Physiology, Shanghai. They were kept in a temperature controlled environment (218C) on a 12:12 h light:dark cycle with ad lib access to food and water.
6-OHDA lesion and behavioral tests: All surgery thus was performed under ketamine and xylazine anesthesia and adequate measures were taken to minimize pain or discomfort. Unilateral DA denervation of the striatum was achieved by stereotaxic injections of 6-OHDA into the right ascending medial forebrain bundle. In rat, 4 ìl 6-OHDA (2 ìg/ìl in 0.2 mg/ml ascorbate±saline) were injected at 4.4 mm caudal to bregma, 1.2 mm lateral to midline, 7.8 mm below dura. Sham-lesioned animals received 4 ìl ascorbate vehicle. The lesion parameters used in the present study result in the selective destruction of virtually all dopaminergic neurons in the SN (. 95%) and the ventral tegmental area (. 80%), as indicated by reduction in mRNA level of tyrosine hydroxylase (TH) [10] , DA contents and TH immunoreactivity [11] . The SN in mice were lesioned with 6-OHDA in the similar way (coordinates: 2.92 mm caudal to bregma, 1.2 mm lateral to midline, 4.35 mm below dura), according to the mouse atlas of Franklin et al. [12] .
Two weeks after lesion, rotational behavior was assessed with apomorphine (Sigma, 0.5 mg/kg, i.p.). Animals that exhibited adequate turning (> 6 full body turns/min for rats and three full body turns/min for mice contralateral to the lesion side) were used for the further study.
RNA isolation and RT-PCR: The animals were sacri®ced at various time points after lesion and the brains were quickly removed. At each time point, four to ®ve 6-OHDAlesioned animals and three sham controls were used. The striata from the lesion side were dissected and stored at À708C until use. The tissues were homogenized and total RNA was isolated using a TOTALLY RNA isolation kit (Ambion, USA). Single strand cDNA was synthesized from 1 ìg total RNA in a volume of 20 ìl containing 50 pmol random hexamers (Gibco, BRL), 50 mM Tris±HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 50 mM DTT, 0.75 U RNasin (Promega), 0.2 mM each of dATP, dCTP, dGTP, and dTTP, and either 200 U or no MMLV reverse transcriptase (Gibco BRL). Reactions were incubated for 1 h at 378C, terminated by heating for 5 min at 958C, and stored at À708C. Table 1 listed oligonucleotide PCR primers designed to amplify the regions. Primers were also designed to amplify regions of coding sequence from glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. Negative control templates for each set of PCR reactions included H 2 O to show that no contaminants were introduced during reaction preparation. Ampli®cation was performed with thermal cycler 2400 (Perkin-Elmer) in a volume of 60 ìl containing 3±5 ìl template, 25 pmol each primer and 1.25 U Taq polymerase (Promega) in 13 PCR buffer, 0.2 mM each of dATP, dGTP, dCTP and dTTP, 1.5 mM MgCl 2 . Cycle conditions consisted of 5 min at 948C for the number of cycles listed in Table 1 , followed by 728C for 7 min. To conduct semi-quantitative RT-PCR, the concentration of GAPDH cDNA of each sample was adjusted to the same level before PCR ampli®cation. The ampli®cations were carried through 25, 30 and 35 cycles.
Twenty-microliter aliquots of each PCR product from the ampli®cation reactions were analyzed on ethidium bromide-stained 1.5% agarose gel electrophoresis. Reaction products were visualized with a u.v. transilluminator. Photos were taken and the optical densities of ampli®ed Note: Of any pair, the ®rst primer is forward, the second reverse. All PCR reactions were performed with hot-start.
NEUROREPORT bands at the end of 35 cycles, except for GAPDH (22 cycles), were measured with Kodak DC120 gel documentation system. All PCR products obtained were sequenced using an automated PCR sequencer (ABI Prism System, Perkin-Elmer). Statistical analysis used commercially available statistical software (GraphPad Prism v2.0, GraphPad Software Inc.). The data were submitted to a one-way ANOVA followed by the Dunnet test (as a post-hoc test). Differences were considered signi®cant at p , 0.05.
RESULTS
The results obtained with sham-operated animals demonstrated the presence of mRNA of GDNF family members in the striatum ipsilateral side. The results were identical for both normal and sham control, showing that the injection procedure alone had not affected expression of growth factor mRNA investigated in this study. In contrast to the sham control, the 6-OHDA lesion resulted in pronounced increases of ampli®cation products for all GDNF family members in the striatum of lesion-side.
To control for the presence of contaminating DNA in the RNA samples, all samples were analyzed with electrophoresis and some of the samples were also run without reverse transcriptase enzyme. No bands were ever observed in these samples using primers speci®c for either GDNF family members or GAPDH in these samples. For each run of RT-PCR on tissue sample, a water blank sample consisting of no RNA was used to control for potential carry-over between samples. Again, no bands were ever observed in the blank sample lane with primers for either trophic factors or GAPDH. All PCR ampli®ca-tions were carried through 25, 30 and 35 cycles apart from GAPDH (22 cycles). We observed that intensities of ampli®ed signal increased through 25, 30 and 35 cycles (data not shown).
The rat neonatal brain was used to establish the RT-PCR assay for GDNF mRNA expression [7] . RT-PCR of P0 striatum RNA with GDNF primers yielded a major band of the predicted size of $622 bp, as well as a minor band of $544 bp. Its expression level in striatum was higher than that of cerebrocortex and hippocampus. This was consistent with the results of Choi-Lundberg et al. [13] . Sequence analyses of these products revealed that the major band was identical to the predicted 622 bp product from PCR of GDNF cDNA. The minor band was identical to the major product except for a deletion of 78 bp, corresponding to nucleotides 123±200 of the rat GDNF cDNA sequence.
The level of GDNF mRNA was increased in the ipsilateral striatum signi®cantly after lesion. It appeared as a very faint band in sham control striatum. However, its expression level was increased 2 weeks post-lesion and reached the maximal level 7 weeks following the lesion (F 22.31, p , 0.05). It then declined and became undetectable 11 weeks after surgery ( Fig. 1a,c ; Table 2 ).
RT-PCR of adult striatum with PSP primers yield a Fig. 1a,d ; Table 2 ). Sequence analyses revealed that the major band was identical to the predicted 328 bp product from PCR of PSP cDNA and it was also identical to the 240 bp shorter one, except for the interruption of an 88 bp intron corresponding to nucleotides 154±241 of the rat PSP cDNA sequence.
To determine the expression level of NTN and ART mRNAs in the ipsilateral striatum after 6-OHDA-induced lesion, the primers speci®c for mouse tissue were designed and ipsilateral striata of mice were used, since the rat gene sequences of NTN and ART had not been reported at the time of this report. Results of RT-PCR with NTN primers of striatum are presented in Fig. 1b,e and Table 2 . No marked increases in NTN mRNA were found in the striatum at either 3 or 7 weeks after 6-OHDA injection, compared with saline-injected control animals (F 0.73, p . 0.05).
Upregulation of ART mRNA levels in the striatum was, however, observed 3 weeks post-lesion (F 4.93, p , 0.05). It returned to control level 7 weeks post-injection (Fig. 1b,e ; Table 2 ). Both NTN and ART transcripts were identical to that predicted as revealed by sequence analysis.
To determine whether DA depletion of striatum results in changes on mRNA levels of non-GDNF family, such as neurotrophins, the mRNA level of BDNF in striatum was examined. Three transcripts were observed, 364 bp, 242 bp and 196 bp in size, respectively (Fig. 1a) . Sequence analysis showed that the band of 342 bp was identical to rat BDNF cDNA as expected (nucleotides 463±826). It showed signi®-cant elevations 2 and 5 weeks post-injury and reached its maximum at 7 weeks post-injury (F 15.47, p , 0.05; Fig. 1d, Table 2 ). Interestingly, the band in the middle (242 bp) had high homology (84.8%) with the newly identi®ed gene coding for GAMM1 protein (Genbank accession No. AF252701) and the minor band shared partial sequence with rat BDNF cDNA sequence (nucleotides 463±482).
DISCUSSION
The present study demonstrates that mRNA expression of GDNF, PSP, ART and BDNF were increased in the adult striatum following selective destruction of the DA nigrostriatal pathway. The increases were time-dependent following lesion. These data suggest that 6-OHDA-induced lesions can change gene expression in denervated target tissue, and that mRNA levels of most GDNF family members in striatal cells may be modulated by afferent dopaminergic input.
Various brain insults can cause transient up-regulation of trophic factor gene expression. For instance, unilateral transection of the angular bundle, which relays cortical information via the entorhinal cortex to the hippocampal formation, increases NGF and BDNF mRNA in the ipsilateral dentate gyrus. Thus, within 4 h following transection, NGF and BDNF mRNA levels increased in stratum granulosum 3-and 5-fold, respectively, compared to control levels. This lesion-induced increase of both mRNAs returned to control levels within 24 h and was maintained for at least 5 days [14] . Systemic injection of kainic acid resulted in a similar situation in the hippocampus [15] . It should be noted that alterations in a given gene expression following various brain insults were short-term and transient (i.e. hours and/or days). However, the increases in striatal gene expression of GDNF family members (except for NTN) and BDNF observed in the present study were slow-rising and long-lasting up to 7 weeks.
The ®ndings of the present study provide evidence that GDNF family members are expressed in low levels in the adult rodent CNS. Multiple forms of GDNF and PSP exist in the striatum, whose expressions are differentially regulated between normal and injured striatum. Studies using RT-PCR have demonstrated the existence of two GDNF isoforms derived from alternative RNA splicing, i.e. a major band of the predicted size of 622 bp, as well as a minor band of 544 bp from rat tissues. The 78 bp deletion is located in nucleotides 123±200 of rat GDNF cDNA, corresponding to amino acids 26±51 [13, 16] . The location and sequence of this deletion observed in the present study were identical to that reported by Choi-Lundberg [13] . Although the function of these multiple transcript forms is not known at this time, there is indication that they may be involved in intrinsic mechanisms to protect injured brain. Schaar et al. has identi®ed astrocyte-derived trophic factors (ATF) from rat astrocyte culture and striatum [17] . Sequence analysis of ATF-1 revealed a 78 bp deletion corresponding to a loss of 26 amino acids within the prepro region of the predicted GDNF protein. The result of biological assay of ATF-1 showed that its transcript encodes a protein that exerted trophic effect on cultured nigral dopaminergic neurons. Since the sequence of the minor transcript identi®ed in the present study was identical to ATF-1, it is very likely that the minor transcript of GDNF encodes a protein that is biologically active in the striatum against DAergic destruction. A large body of evidence suggests that GDNF is a relatively speci®c trophic factor for nigral DA neurons. For instance, GDNF exerts trophic effects on cultured nigral DA neurons, but does not affect basal forebrain cholinergic neurons [17] . Moreover, GDNF selectively protects DA neurons in vivo, compared with 5-HT neurons, against the neurotoxic effects of methamphetamine [18] . It has been shown that GDNF infusion for 5À9-weeks rescued nigral DA neurons in 6-OHDA-lesioned rat, suggesting that loss of DA phenotype contributes to disappearance of TH immunoreactivity in SN following 6-OHDA lesion and that GDNF restores the phenotype of affected cells [19] . The failure of restoring DA phenotype by striatal GDNF in the present study (data not shown) may be in part due to insuf®cient production of endogenous GDNF in striatum following lesion. Future investigation on ways to increase the production of endogenous GDNF in the injured brain (e.g. to stimulate its synthesis pharmacologically) may be useful to develop novel therapy for Parkinson's disease.
Consistent with previous studies [3] , two transcripts of rat PSP gene, derived through alternative splicing were also observed in this study. Compared to GDNF and other growth factors investigated in the present study, the pattern of PSP expression observed in the striatum was similar to that seen in GDNF, i.e. levels of both two bands were signi®cantly increased in the striatum after 6-OHDAlesion. However, the signi®cance of increased production of the spliced transcript in the striatum is not clear. PSP has been identi®ed using molecular biology techniques based on its homology in gene sequence with GDNF. It promotes the survival of ventral midbrain DA neurons in culture and prevents their degeneration after 6-OHDA treatment in vivo [3] . The exact roles of each PSP transcripts in eventual differential expression remain to be elucidated.
It has been well established that BDNF supports survival of various sets of the mammalian nervous system. Given that BDNF supports the survival of midbrain DA neurons in cell culture [20] and DA depletion of striatum results in elevation of protein [8] and mRNA levels of BDNF, it is concluded that BDNF is a typical target-derived neurotrophic factor. Striatal BDNF levels change in response to brain injury such as 6-OHDA-induced nigrostriatal destruction. However, the appearance of 242 bp and 196 bp transcripts and their subsequent elevation found in this study was unexpected and has not been reported previously. Published studies indicated that using a set of similar primer with that employed in the present study, only a 364 bp transcript in mouse SN was ampli®ed [21] . The discrepancy between these results and ours may be due to differences on brain tissue employed and conditions of PCR ampli®cation.
It has been shown that 6-OHDA injection in nigrostriatal pathway results in various changes in both striatum and SN, such as signi®cant elevation of trkB receptor in striatum [22] and differential expression of nicotinic acetylcholine receptor subunit mRNA in SN [23] . These changes may be an early step in the synaptic rearrangement of neurotrophic factor responsive DA afferents observed following damage to the nigrostriatal pathway. Furthermore, selective destruction of nigrostriatal DA pathway would produce signi®cant neurotrophic activity speci®c to DA neurons [24] . Our recent ®ndings indicate that BDNF and other trophic factors present in the striatal extracts may contribute to the activity [25] .
CONCLUSION
The evidence presented in this study suggests that loss of afferent DA input in striatum up-regulates mRNA expression of neurotrophic factors. The expression of multiple transcripts in a region-speci®c fashion implies complex regulation of nigral trophic factor gene expression and gene product processing. Further understanding of this process may be important for reconstruction of damaged neural circuits and development of novel agents for treatment of neurodegenerative diseases, such as Parkinson's disease.
